Activating alterations in receptor tyrosine kinases and downstream effectors converge on core signaling cascades, including the RAS–RAF–MEK–ERK, PI3K–AKT–mTOR, and JAK–STAT pathways, promoting tumor cell proliferation, angiogenesis, and survival. The gene discussed is NTRK1; the disease is neoplasm.